Market revenue in 2023 | USD 66.9 million |
Market revenue in 2030 | USD 109.7 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.89% in 2023. Horizon Databook has segmented the Brazil intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is one of the largest economies in Latin America and the fifth most populous country in the world. It is showing an upward trend in aging population and is expected to have a growth of 18.6% of the total population by 2030, according to WHO.
The population in developing economies such as Brazil is aging, with a majority of the aged individuals in lower income brackets. Cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases are on the rise in Brazil, mainly because of the growth in risk factors such as tobacco use, unhealthy diets, physical inactivity, and alcohol abuse.
There has been a significant rise in cases of breast cancer, with 57,960 new cases recorded in 2018, mainly from the city of São Paulo. This has led to an increase in anticancer treatments and surgeries in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into Brazil intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account